Related Experiment Videos
Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies
Abstract:
Natural killer (NK) cells have been implicated as an initial immunosurveillance mechanism for carcinogenesis in humans. Work in the murine system as well as the findings of depressed NK activity in patients with advanced malignancies and the discovery of increased incidences of cancer in humans congenitally deficient in NK ability have supported this. Few prospective studies have demonstrated a prognostic change in NK activity with respect to malignant disease course. In 32 healthy donors, NK activity against K562 was determined. No race or sex difference existed with respect to NK cell function. Esophageal (5), bronchogenic (3), breast (3), cervical (3), and endometrial (1) cancer patients who had received no prior chemotherapy were compared to controls. All patients subsequently received radiotherapy. Prior to such treatment NK activity could not be associated with stage of malignancy. Of the 15 patients studied, 11 were sequentially followed. Five of eight patients with stable or improving clinical courses as assessed by weight and Karnofsky scores were found to have increasing NK activity. Two of three patients with poor clinical courses presented with subnormal killing which never rose to normal while the third declined to subnormal before expiring. Esophageal, cervical, and endometrial carcinoma patients all presented with low or subnormal NK activity. Of these, only cervical and endometrial cancer patients exhibited an increase to normal levels.
Insights
Natural killer (NK) cell activity shows potential as a prognostic indicator in cancer patients. Increased NK activity correlated with stable or improving clinical courses, suggesting its role in monitoring disease progression.
Area of Science:
- Immunology
- Oncology
Background:
- Natural killer (NK) cells are crucial for immunosurveillance against cancer.
- Depressed NK activity is observed in advanced malignancies, and NK cell deficiency is linked to increased cancer incidence.
Purpose of the Study:
- To investigate the prognostic value of NK cell activity in cancer patients.
- To determine if NK activity changes correlate with clinical disease course.
Main Methods:
- NK cell activity was measured against K562 target cells in 32 healthy donors and cancer patients (esophageal, bronchogenic, breast, cervical, endometrial) before radiotherapy.
- Sequential follow-up of 11 patients assessed changes in NK activity alongside clinical status (weight, Karnofsky scores).
Main Results:
- No significant NK activity differences based on race or sex.
- Pre-treatment NK activity did not correlate with cancer stage.
- Increasing NK activity was observed in 5/8 patients with stable or improving clinical courses.
- Patients with poor clinical outcomes showed persistently subnormal or declining NK activity.
Conclusions:
- NK cell activity may serve as a prognostic marker in cancer.
- Changes in NK activity can reflect disease progression or response to treatment.
- Cervical and endometrial cancer patients showed initial low NK activity that normalized with treatment.